US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle

      Summary Company Announcement Date: March 23, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Featured / The Devastating Truth About Risperdal and Gynecomastia

The Devastating Truth About Risperdal and Gynecomastia

October 6, 2015 By US Recall News Leave a Comment

Early Risperdal data from before 1994 when the Johnson and Johnson drug was first licensed, for use in certain psychotic patients, showed that the negative effects on children were considerable, with the following list of common side effects:

  • 51% – Somnolence i.e. feeling drowsy or sleepy.
  • 29% – Headaches.
  • 20% – Vomiting.
  • 15% – Stomach ailments, bloating and nausea.

Additionally, even at the time when the drug was first licensed it has now emerged that trial data indicated that significant weight gain was common and that there were a large number of adolescent boys who developed male breast tissue (gynecomastia) because of taking the drug.

Gynecomastia is listed as a side effect on the safety label that is issued by the FDA, but it is certainly not prominent. The document itself runs to 99-pages and there are only three brief mentions, which in total make up about four-lines out of the thousands.

The most significant of these mentions is two-lines on page 33 that casually reports that gynecomastia occurred in 2.3% of adolescents in one study from February 1999.

The real-world incidents of gynecomastia because of taking Risperdal, as well as increasing amounts of study data, would seem to challenge how high that number really is, with some commentators putting the real number from that 1999 study, in any case, as 4.5% among adolescent boys.

The Wall Street Journal on their Health Blog reported as far back as November 2008 on how “Risperdal Can Have Troubling Side Effects in Boys”, and how six boys’ legal cases were already underway in Philadelphia because of the link between using Risperdal and the growth of excess breast tissue.

One of those Philadelphia cases has now reached judgement in February 2015 and $2.5 million was awarded in damages to Austin Pledger, an autistic boy who is now 21, who had grown 46DD breasts because of taking Risperdal.

The study data that shows the link between Risperdal and gynecomastia has also grown over the years.

A study in 2006 showed that 3 out of 10 adolescent male patients developed gynecomastia following the use of Risperdal. Another from 2009 showed that using Risperdal in adolescents elevated prolactin levels (implicated in gynecomastia) for two-years following use. In addition, an August 2015 study is most damning of all, showing:

“Current users of risperidone (which is the generic name for Risperdal) had approximately four times the risk of developing gynecomastia than non-users. When the analysis was stratified to children and adolescents (≤18 years of age) taking risperidone, the risk of gynecomastia was five times higher than for non-users.”

Moreover, these studies are by no means isolated cases. A search on the U.S Library of Medicine shows 27 different studies that have been undertaken since 1998 investigating a link between risperidone and gynecomastia. This body of work is interesting both from the mounting evidence that Risperdal causes a greater risk of gynecomastia in adolescent boys, but also because it now seems that the risk against adults may be greater than was previously suspected.

It seems clear that Risperdal and gynecomastia deserve more than a couple of warning lines in a 99-page document, and that anyone who suspects they may have been affected between 1994 and today would be well-advised to urgently seek out legal advice.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: Featured, Risperdal Tagged With: Risperdal

About US Recall News

US Recall News provides recall news and information to the United States general public. Find all of the latest drug, food, products, and vehicle recall news as reported by U.S. government agencies and more.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle

March 23, 2023 By The FDA

Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards

March 22, 2023 By The CPSC

Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)

March 22, 2023 By The CPSC

Free Case Review

  • * = Required
    Privacy Policy
  • This field is for validation purposes and should be left unchanged.

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces

March 20, 2023 By The FDA

Voluntary Recall of One Lot of Kaytee® Wild Bird Food Birders Blend, 8 Lb Bag, Due to Elevated Levels of Aflatoxin

March 18, 2023 By The FDA

Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula

March 16, 2023 By The FDA

Mockingbird Expands Recall to Include Single Strollers Due to Fall Hazard

March 16, 2023 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula

March 16, 2023 By The FDA

Mockingbird Expands Recall to Include Single Strollers Due to Fall Hazard

March 16, 2023 By The CPSC

Updated – Scenic Fruit Company Recalls Frozen Organic Strawberries and Frozen Organic Tropical Blend Because of Possible Health Risk

March 15, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle
  • Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards
  • Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)
  • Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
    Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
    (Recall Alert)
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
  • Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”
  • Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces
  • Voluntary Recall of One Lot of Kaytee® Wild Bird Food Birders Blend, 8 Lb Bag, Due to Elevated Levels of Aflatoxin
  • Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in